VolitionRX Ltd (VNRX) poses a Brand-New Opportunity for Investors with beta value of 1.29

Shaun Noe

VolitionRX Ltd (AMEX: VNRX) open the trading on Thursday, with great promise as it jumped 24.19% to $0.35, before settling in for the price of $0.29 at the close. Taking a more long-term approach, VNRX posted a 52-week range of $0.22-$0.94.

It was noted that the giant of the Healthcare sector posted annual sales growth of 5.38% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 5.38%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 31.72%. This publicly-traded company’s shares outstanding now amounts to $109.62 million, simultaneously with a float of $97.40 million. The organization now has a market capitalization sitting at $43.56 million. At the time of writing, stock’s 50-day Moving Average stood at $0.3205, while the 200-day Moving Average is $0.5263.

VolitionRX Ltd (VNRX) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Devices industry. VolitionRX Ltd’s current insider ownership accounts for 20.69%, in contrast to 21.27% institutional ownership. According to the most recent insider trade that took place on Nov 17 ’25, this organization’s President and CEO bought 20,000 shares at the rate of 0.35, making the entire transaction reach 7,000 in total value, affecting insider ownership by 2,554,847. Preceding that transaction, on Oct 14 ’25, Company’s President and CEO bought 110,000 for 0.51, making the whole transaction’s value amount to 56,100. This particular insider is now the holder of 2,534,847 in total.

VolitionRX Ltd (AMEX: VNRX) Trading Performance Indicators

Let’s observe the current performance indicators for VolitionRX Ltd (VNRX). It’s Quick Ratio in the last reported quarter now stands at 0.12. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 29.64.

In the same vein, VNRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.23, a figure that is expected to reach -0.05 in the next quarter, and analysts are predicting that it will be -0.11 at the market close of one year from today.

Technical Analysis of VolitionRX Ltd (VNRX)

[VolitionRX Ltd, VNRX] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 89.52% While, its Average True Range was 78.53.

Raw Stochastic average of VolitionRX Ltd (VNRX) in the period of the previous 100 days is set at 25.92%, which indicates a major fall in contrast to 81.06% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0232 that was lower than 0.0367 volatility it exhibited in the past 100-days period.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.